SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-013743
Filing Date
2021-06-07
Accepted
2021-06-07 16:30:41
Documents
13
Period of Report
2021-06-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 57220
  Complete submission text file 0001493152-21-013743.txt   284383

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hrow-20210603.xsd EX-101.SCH 3746
3 XBRL DEFINITION FILE hrow-20210603_def.xml EX-101.DEF 28159
4 XBRL LABEL FILE hrow-20210603_lab.xml EX-101.LAB 37403
5 XBRL PRESENTATION FILE hrow-20210603_pre.xml EX-101.PRE 26774
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5544
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 21999894
SIC: 2834 Pharmaceutical Preparations